Pancreatic Cancer Early Detection Program (PCEDP)
Observational Study to Analyze the Outcomes of Subjects Who - Based Upon Their Sufficiently Elevated Risk for the Development of Pancreatic Adenocarcinoma- Elect to Undergo Early Detection Testing
Sponsor: White Plains Hospital
A observational or N/A phase clinical study on BRCA 1/2 and FAMMM, this trial is ongoing. The trial is conducted by White Plains Hospital and has accumulated 11 data snapshots since 2014. Oncology trials at this stage typically focus on safety, tolerability, and early efficacy signals.
Status Flow
Change History
11 versions recorded-
Sep 2024 — Present [monthly]
Active Not Recruiting
-
Jul 2024 — Sep 2024 [monthly]
Active Not Recruiting
-
Jun 2024 — Jul 2024 [monthly]
Active Not Recruiting
Status: Recruiting → Active Not Recruiting
-
Aug 2023 — Jun 2024 [monthly]
Recruiting
-
Apr 2021 — Aug 2023 [monthly]
Recruiting
▶ Show 6 earlier versions
-
Jan 2021 — Apr 2021 [monthly]
Recruiting
-
Feb 2020 — Jan 2021 [monthly]
Recruiting
-
May 2019 — Feb 2020 [monthly]
Recruiting
-
Jun 2018 — May 2019 [monthly]
Recruiting
-
Apr 2018 — Jun 2018 [monthly]
Recruiting
Phase: NA → None
-
Jan 2017 — Apr 2018 [monthly]
Recruiting NA
First recorded
Apr 2014
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- White Plains Hospital
For direct contact, visit the study record on ClinicalTrials.gov .